Cerba Research
Leen Catrysse has worked as a Flow Cytometry Scientist at Cerba Research since 2020. Prior to that, they worked at VIB-UGent as a Postdoctoral Researcher from 2017 to 2020 and as a PHD Researcher from 2011 to 2017. During their PHD, they focused on studying inflammation in the development of obesity and type 2 diabetes in vivo, with a particular emphasis on metabolic tissues. Leen also has experience as a Thesis student at DMBR in 2011.
Leen Catrysse obtained their Doctor of Philosophy - PhD in Biotechnology and Biochemistry from Ghent University, which they attended from 2011 to 2017. Prior to their doctoral studies, they completed their Master's degree in Biochemistry and Biotechnology at Ghent University from 2007 to 2011. However, no specific information is provided regarding their earlier education at Bisschoppelijk college Veurne.
Cerba Research
Cerba Research is the result of the merger of three companies: Barc Lab, Histalim, and Cerba Xpert. Cerba HealthCare owns all three companies and has opted to unite them under one banner. Cerba Research offers quality offers laboratory and diagnostic services, while also harnessing patient data and scientific expertise to help plan and advanceclinical trials. They help global biotech, pharma, and IVD firms to enhance the lives of patients throughout the world by using their worldwide footprint and access to premier regional labs, data, patients, technology, and partnered resources.